Attached files
| file | filename |
|---|---|
| EX-32 - EXHIBIT 32.1 - EASTGATE BIOTECH CORP | exhibit32.1.htm |
| EX-31 - EXHIBIT 31.2 - EASTGATE BIOTECH CORP | exhibit31.2.htm |
| EX-31 - EXHIBIT 31.1 - EASTGATE BIOTECH CORP | exhibit31.1.htm |
| 10-Q - EASTGAT BIOTECH - 10Q -JUNE 30, 2017 - Q2 - EASTGATE BIOTECH CORP | eastgatebiotechq2_2017.htm |
Exhibit 32.2
Certification of Principal Financial and Accounting Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Rose Perri., the Chief Financial Officer of Eastgate Biotech Corp., a Nevada corporation (the "Company"), hereby certify, that, to my knowledge:
1.
The Quarterly Report on Form 10-Q for the period ended June 30, 2017 (the "Report") of the Company fully complies with the requirements of Section 13(a)/15(d) of the Securities Exchange Act of 1934; and
1.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 17, 2018
| | By: /s/ Rose Perri Name: Rose Perri Title: Chief Financial Officer (Principal Financial and Accounting Officer) |